The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
even though I believe the the primary defect is in the signaling pathway there's clearly severe impairments and glucose transport and phosphorilation his work would suggest that the primary defect is at the level of glucose transport we did we developed a novel triple tracer technique using three Isotopes infused into the brachial artery we believe that the primary defect is at the level of hexokinase and phosphor uh glucose so we kind of agree to disagree
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.